Praxair (NYSE: PX), Danbury, CT, reported full year sales of $11.9 billion for 2013, a 6 percent increase from 2012. Profit increased 5 percent to $1.8 billion.

Sales for the fourth quarter were $3 billion, an 8 percent increase from the same period a year ago, with organic sales increasing 7 percent. Profit increased 12 percent to $474 million.

North American sales were $1.6 billion for the quarter, an increase of 11 percent, with 6 percent in organic sales. European sales increased 11 percent to $404 million.

Fourth-quarter sales in South America were $481 million, a decrease of 1 percent, but underlying sales increased 9 percent. Sales in Asia were $394 million, up 5 percent.